In this article we demonstrate the isolation of murine resident lung mesenchymal stem cells (lung MSC), their expansion, characterization and analysis of immunomodulatory properties.
Tissue resident mesenchymal stem cells (MSC) are important regulators of tissue repair or regeneration, fibrosis, inflammation, angiogenesis and tumor formation. Taken together these studies suggest that resident lung MSC play a role during pulmonary tissue homeostasis, injury and repair during diseases such as pulmonary fibrosis (PF) and arterial hypertension (PAH). Here we describe a technology to define a population of resident lung MSC. The definition of this population in vivo pulmonary tissue using a define set of markers facilitates the repeated isolation of a well-characterized stem cell population by flow cytometry and the study of a specific cell type and function.
1. Lung Isolation
2. Preparation of a Single Cell Suspension from Lung Tissue
3. Staining and Preparation of the Lung Cell Suspension for Flow Cytometry Analysis
4. Flow Cytometry Analysis to Define and Isolate a Lung Mesenchymal Stem Cell (lung MSC) Population using Hoechst dye Efflux to Detect a Side Population (SP)
5. Isolation, Culture and Characterization of lung MSC and Clones
6. Enumeration of lung MSC using a Colony Forming Assay (CFU-F)
7. Analysis of the Immunomodulatory Properties of lung MSC on T-cell Proliferation and Apoptosis
8. Representative Results:
Figure 1. Flow cytometric analysis and Definition of Lung MSC. Single cell suspensions of lung tissue digest are stained with Hoechst 33342 and analyzed by flow cytometry to detect differences in A. forward scatter (FSC) and side scatter (SSC) and B. Hoechst blue and red fluorescence. The presence of a side population (SP) is visible in the gate. The Hoechstlow SP is then analyzed to separate the C. CD45negative population of lung MSC. The CD45 positive to negative ratios of lung SP are typically 70:30 / 60:40.
Figure 2. Isolation and Culture of Lung MSC. Following collection of the lung MSC by cell sorting, the cells are plated in 30mm dishes using α-MEM supplemented with 20% FBS. A. Freshly sorted cells appear small, round and bright. B. After approximately 2-3 weeks colonies with a mesenchymal phenotype become evident and proliferation is more obvious.
Figure 3. Enumeration of MSC by Colony Forming-Fibroblast Assay. Expanded lung MSC are plated per the described protocol for the CFU-F assay. A. After 10 days and Giemsa stain colonies are evident. B. Colonies are large and comprised of a few hundred cells. C. The cells display a mesenchymal phenotype. A & B, Scale bar =0.5 cm; C Scale bar = 0.14 cm.
Figure 4. CFSE Based T cell Proliferation Assay. In the absence of lung MSC and presence of antigen presenting cells (APC) +/- ovalbumin (OVA) CD40positive effector T cell demonstrate a decrease in CFSE intensity which indicates proliferation (red circle). CFSE fluorescence intensity of the T-cell membrane decreases stoichiometrically with every cell division ie. with every division. In the presence of lung MSC, APC +/- OVA, CD40positive effector T cell demonstrate no significant change in CFSE intensity which indicates a lack of proliferation (red circle).
We have adapted a method initially used to identify BM hematopoietic cells to isolate a specific population of resident lung MSC. Due to the reproducibility of isolation these cells were then well characterized as MSC. Their origin has been defined as resident in the adult mouse lung (as opposed to BM derived) and a phenotypic and molecular profile documented 2. The ability to repeatedly isolate this characterized population allows the further study of the biological importance and role of the lung MSC during tissue homeostasis and disease. The recent definition of this population in vivo in both murine and human pulmonary tissue facilitates the development of a therapeutic strategy directed at the rescue of endogenous cells to facilitate lung repair during injury and disease.
The authors have nothing to disclose.
This work was funded by grants to SMM: AHA GIA0855953G, NIH 1R01 HL091105-01. Additional support was provided by: DW: NIH RO1DK075013, DDK and the Kleberg Foundation; the UCCC Flow Cytometry Core (NIH 5 P30 CA 46934-15), the UCCC Microarray core (NCI P30 CA 46934-14).
Name of the reagent | Company | Catalogue number | Comments (optional) |
---|---|---|---|
Phosphate buffered saline (PBS) | Sigma | P-5368 | |
Hanks buffered salt solution (HBSS) | Thermo Scientific | SH30588.01 | |
0.2% Worthington type 2 collagenase | Worthington Biochemicals | LS004202 | |
Red blood cell lysis buffer | eBiosciences | 00-4333-57 | |
DMEM | Invitrogen Gibco | 11965-092 | |
Hoechst 33342 dye | Sigma | B2261 | |
CD45-APC | BD Pharmingen | 559864 | |
Propidium iodide | Sigma | 81845 | |
a-MEM | Thermo Scientific | SH30265.01 | |
FBS | Invitrogen | 16000-069 | |
0.5% trypsin/EDTA | Cellgro | 25-053-Cl | |
Complete MesenCult Medium | Stem Cell Technologies | 05511 | |
0.4% w/v Giemsa staining solution | Sigma | GS1L | |
4% paraformaldehyde | Electron Microscopy Services | 15710 | 16% paraformeldehyde is diluted to 4% using PBS |
Carboxyfluorescein succinimidyl ester (CFSE) | Sigma | 21888 |